Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Super Speciosa is a prominent provider of kratom (Mitragyna speciosa) products, including powders, capsules, and specialized tablets. Founded in 2013, the company has established itself as a leader in the herbal supplement industry through a focus on quality control and consumer safety. It was among the first vendors to be recognized as a Good Manufacturing Practices (GMP) Qualified Vendor by the American Kratom Association. The company emphasizes transparency by providing batch-specific lab certificates for every product, accessible via QR codes. Super Speciosa's products are marketed for various wellness applications such as energy enhancement, relaxation, and discomfort relief.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Super Speciosa.